[Federal Register Volume 82, Number 249 (Friday, December 29, 2017)] [Notices] [Page 61795] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 2017-28176] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Importer of Controlled Substances Application: ABBVIE LTD; Correction ACTION: Notice; correction. ----------------------------------------------------------------------- SUMMARY: The Drug Enforcement Administration (DEA) published a document in the Federal Register of December 1, 2017, concerning a notice of application that inadvertently misstated what the firm plans to do with imported tapentadol. Correction In the Federal Register of December 1, 2017, in FR Doc. 2017-25921 (82 FR 230), on page 230, in the second column, the last paragraph, correct the first sentence to read: The company plans to import bulk tapentadol (9780) to manufacture dosage form tapentadol (9780) for distribution to its customers. Demetra Ashley, Acting Assistant Administrator. [FR Doc. 2017-28176 Filed 12-28-17; 8:45 am] BILLING CODE 4410-09-P